Chemical Structure (Losartan Potassium 25mg 1)
Losartan Potassium
Product Images NDC 53217-369
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 53217-369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Losartan Potassium 25mg 2)
This is a comparison between two medications: Atenolol and Losartan Potassium, with a table showing the percentage of patients who achieved the primary endpoint. The adjusted risk reduction is 13% with a p-value of 0.021. The graph shows the study month from 0 to 66, with data points at various intervals.*
Figure 2 (Losartan Potassium 25mg 3)
Figure 3 (Losartan Potassium 25mg 4)
The text describes the results of a study on the incidence of stroke in patients taking either Losartan or Atenolol. The study includes demographic subgroups such as age, gender, race, ISH, diabetes, and history of CVD. The primary endpoint of the study is a composite of fatal and non-fatal strokes. The text includes data on the number of events, rate, and hazard ratio for both medications. The results are displayed in a table with symbols proportional to sample size. The text is not readable due to formatting issues.*
Figure 4 (Losartan Potassium 25mg 5)
This appears to be a presentation of the results of a clinical trial or study comparing the effectiveness of Losartan Potassium to a placebo. The data includes the percentage of patients with an event (which is not specified) and a graph that shows the percentage of patients over time. The study found a risk reduction of 16.1% with a p-value of 0.022. The graph shows a timeline of 48 months, divided into 4 equal sections (0-12, 12-24, 24-36, 36-48).*
53217-0369_losartan-pot_25mg (Losartan Potassium 25mg 6)
Not available. The text is only a single character and a trademark symbol.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
